Health Catalyst - HCAT Competitors

Century Therapeutics (NASDAQ:IPSC) and Health Catalyst (NASDAQ:HCAT) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk, media sentiment, community ranking and analyst recommendations.

Does the media prefer IPSC or HCAT?

In the previous week, Health Catalyst had 1 more articles in the media than Century Therapeutics. MarketBeat recorded 12 mentions for Health Catalyst and 11 mentions for Century Therapeutics. Health Catalyst's average media sentiment score of 0.61 beat Century Therapeutics' score of 0.55 indicating that Health Catalyst is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Century Therapeutics	0 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Health Catalyst	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders and institutionals hold more shares of IPSC or HCAT?

57.5% of Century Therapeutics shares are held by institutional investors. Comparatively, 97.5% of Health Catalyst shares are held by institutional investors. 10.3% of Century Therapeutics shares are held by company insiders. Comparatively, 1.5% of Health Catalyst shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Do analysts rate IPSC or HCAT?

Century Therapeutics presently has a consensus price target of $27.00, indicating a potential upside of 110.61%. Health Catalyst has a consensus price target of $26.69, indicating a potential upside of 97.14%. Given Century Therapeutics' higher possible upside, analysts clearly believe Century Therapeutics is more favorable than Health Catalyst.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Century Therapeutics	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80
Health Catalyst	0 Sell rating(s)	2 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.92

Which has more risk & volatility, IPSC or HCAT?

Century Therapeutics has a beta of 0.33, suggesting that its share price is 67% less volatile than the S&P 500. Comparatively, Health Catalyst has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500.

Which has better valuation and earnings, IPSC or HCAT?

Century Therapeutics has higher earnings, but lower revenue than Health Catalyst. Century Therapeutics is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Century Therapeutics	N/A	N/A	-$95.82 million	-$1.92	-6.68
Health Catalyst	$241.93 million	3.06	-$153.21 million	-$2.92	-4.64

Is IPSC or HCAT more profitable?

Century Therapeutics has a net margin of 0.00% compared to Health Catalyst's net margin of -54.64%. Health Catalyst's return on equity of -18.31% beat Century Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Century Therapeutics	N/A	-31.39%	-24.66%
Health Catalyst	-54.64%	-18.31%	-11.16%

Does the MarketBeat Community believe in IPSC or HCAT?

Health Catalyst received 114 more outperform votes than Century Therapeutics when rated by MarketBeat users. Likewise, 71.10% of users gave Health Catalyst an outperform vote while only 45.00% of users gave Century Therapeutics an outperform vote.

Company	Underperform	Outperform
Century Therapeutics	Outperform Votes 9 45.00%	Underperform Votes 11 55.00%
Health Catalyst	Outperform Votes 123 71.10%	Underperform Votes 50 28.90%

Summary

Health Catalyst beats Century Therapeutics on 13 of the 18 factors compared between the two stocks.